Alopecia
January 2018
in “
Elsevier eBooks
”
alopecia scarring alopecia nonscarring alopecia androgenic alopecia finasteride minoxidil antiandrogenic agents telogen effluvium trichotillomania traction alopecia alopecia areata tinea capitis lupus erythematosus-related alopecia Central Centrifugal Cicatricial Alopecia CCCA corticosteroids tetracyclines Propecia Rogaine
TLDR The document concludes that alopecia has various forms, each with specific treatments, but no definitive cure for certain types like CCCA has been proven.
The 2018 document provides a comprehensive overview of alopecia, classifying it into scarring and nonscarring types, and highlighting the importance of patient history and physical examination for diagnosis. It details androgenic alopecia, the most common form, affecting 50% of men and women by age 50, with treatments including finasteride, minoxidil, and antiandrogenic agents. Telogen effluvium, a stress-related diffuse hair loss, and trichotillomania, a compulsive hair-pulling disorder, are also discussed with their respective treatments. The document covers other forms such as traction alopecia, alopecia areata, tinea capitis, and lupus erythematosus-related alopecia, each with specific clinical features and treatments. Central Centrifugal Cicatricial Alopecia (CCCA) is described as a scarring alopecia primarily affecting African American women, with treatments like corticosteroids and tetracyclines, but no definitive treatment to alter its progression has been proven in controlled clinical trials.
